Is It Enough Glucose-Lowering Therapy for Men with Type 2 Diabetes Mellitus and Testosterone Deficiency?

被引：0
|
作者：
Khripun, Irina A.
Bova, Elena V.
Vorobyev, Sergey V.
Dzantieva, Elizaveta O.
Belousov, Igor I.
Kogan, Michail I.
机构：
来源：
DIABETES | 2017年 / 66卷
基金：
俄罗斯科学基金会;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1491-P
引用
收藏
页码：A399 / A399
页数：1
相关论文
共 50 条
  • [21] Dysfunction of Adipose Tissue and Testosterone Deficiency in Men with Type 2 Diabetes Mellitus
    Khripun, Irina A.
    Vorobyev, Sergey V.
    Bova, Elena V.
    DIABETES, 2020, 69
  • [22] Glucose-lowering therapy in patients with type 2 diabetes mellitus depending on the stages of heart failure by the ACCF/AHA classification
    Bayarsaikhan, M. Munkhtsetseg
    Yeshniyazov, N. B.
    Medovchshikov, V. V.
    Khasanova, E. R.
    Kobalava, Z. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 359 - 359
  • [23] Arginase inhibition improves endothelial function in patients with type 2 diabetes mellitus despite intensive glucose-lowering therapy
    Mahdi, A.
    Kovamees, O.
    Checa, A.
    Wheelock, C. E.
    von Heijne, M.
    Alvarsson, M.
    Pernow, J.
    JOURNAL OF INTERNAL MEDICINE, 2018, 284 (04) : 388 - 398
  • [24] Additive Postprandial Glucose-Lowering Effects of Mitiglinide and Sitagliptin in Patients with Type 2 Diabetes Mellitus
    Jin Ah Jung
    Kohei Kaku
    Jae Hyeon Kim
    Jung-Ryul Kim
    Jae-Wook Ko
    Soo-Youn Lee
    Wooseong Huh
    Advances in Therapy, 2013, 30 : 1018 - 1029
  • [25] Cardiovascular prevention in type 2 diabetes mellitus patients: the role of oral glucose-lowering agents
    Anselmino, Matteo
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2009, 23 (06) : 427 - 433
  • [26] New glucose-lowering drugs for reducing cardiovascular risk in patients with type 2 diabetes mellitus
    Gorgojo-Martinez, J. J.
    HIPERTENSION Y RIESGO VASCULAR, 2019, 36 (03): : 145 - 161
  • [27] Personalized glucose-lowering effect of chiglitazar in type 2 diabetes
    Huang, Qi
    Zou, Xiantong
    Chen, Yingli
    Gao, Leili
    Cai, Xiaoling
    Zhou, Lingli
    Gao, Fei
    Zhou, Jian
    Jia, Weiping
    Ji, Linong
    ISCIENCE, 2023, 26 (11)
  • [28] Progression of glucose-lowering diabetes therapy in TECOS
    Bethel, M. Angelyn
    Engel, Samuel S.
    Stevens, Susanna R.
    Lokhnygina, Yuliya
    Ding, Jie
    Josse, Robert G.
    Alvarsson, Michael
    Hramiak, Irene
    Green, Jennifer B.
    Peterson, Eric D.
    Holman, Rury R.
    ENDOCRINOLOGY DIABETES & METABOLISM, 2019, 2 (01)
  • [29] Management of Glucose-Lowering Therapy in Older Adults with Type 2 Diabetes: Challenges and Opportunities
    Doucet, Jean
    Gourdy, Pierre
    Meyer, Laurent
    Benabdelmoumene, Nabil
    Bourdel-Marchasson, Isabelle
    CLINICAL INTERVENTIONS IN AGING, 2023, 18 : 1687 - 1703
  • [30] A Decision Support Tool for Appropriate Glucose-Lowering Therapy in Patients with Type 2 Diabetes
    Javier Ampudia-Blasco, F.
    Benhamou, Pierre Yves
    Charpentier, Guillaume
    Consoli, Agostino
    Diamant, Michaela
    Gallwitz, Baptist
    Khunti, Kamlesh
    Mathieu, Chantal
    Ridderstrale, Martin
    Seufert, Jochen
    Tack, Cees
    Vilsboll, Tina
    Tra-Mi Phan
    Stoevelaar, Herman
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 (03) : 194 - 202
12345